Consensus EPS · Q2 2026
$3.03
Consensus revenue · Q2 2026
$4.3B
Analysts
12
Expected report
Jul 28, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 12 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $4.3B | $4.3B | $4.3B |
| EPS | $2.93 | $3.03 | $3.08 |
| EBITDA | $903.7M | $908M | $912.2M |
| EBIT | $572.2M | $574.9M | $577.6M |
| Net income | $513M | $514.7M | $518.1M |
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $4.2B | $4.1B | +1.2% | $2.90 | $2.82 | +3.0% |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for IQVIA (IQV) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $185.00 | $226.73 | $240.00 | $250.00 | $207.83 | +9.1% |
Upside calculated vs most recent trading price of $207.83.
Analyst ratings
Consensus: Buy — based on 44 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 13, 2026 | Mizuho | maintain | Outperform | Outperform |
| Jul 1, 2026 | Baird | maintain | Outperform | Outperform |
| Jun 17, 2026 | Morgan Stanley | downgrade | Overweight | Equal Weight |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Mar 9, 2026 | TD Cowen | upgrade | Hold | Buy |
| Mar 6, 2026 | Barclays | upgrade | Equal Weight | Overweight |
| Feb 19, 2026 | Truist Securities | maintain | Buy | Buy |
| Feb 6, 2026 | UBS | maintain | Buy | Buy |
| Feb 6, 2026 | Stifel | maintain | Buy | Buy |
| Feb 6, 2026 | JP Morgan | maintain | Overweight | Overweight |
Frequently asked questions
IQVIA (IQV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation